Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4848 USD | -0.84% | -0.35% | -61.52% |
03-11 | BioVie Inc. Announces Pipeline Update and Near-Term Clinical Priorities | CI |
03-04 | Top Midday Decliners | MT |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 26.62M 36.38M |
---|---|---|---|---|---|
Net income 2024 * | -49M -66.98M | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.48
x | P/E ratio 2025 * |
-
| Employees | 18 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 56.72% |
1 day | -0.84% | ||
1 week | -0.35% | ||
Current month | -8.29% | ||
1 month | -8.72% | ||
3 months | -47.25% | ||
6 months | -84.99% | ||
Current year | -61.52% |
Managers | Title | Age | Since |
---|---|---|---|
Cuong Viet Do
CEO | Chief Executive Officer | 58 | 16-04-10 |
Joanne Kim
DFI | Director of Finance/CFO | 59 | 18-09-30 |
Joseph Palumbo
CTO | Chief Tech/Sci/R&D Officer | 64 | 21-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Gorlin
BRD | Director/Board Member | 87 | 20-06-15 |
Richard Berman
BRD | Director/Board Member | 81 | 19-06-23 |
Jim Lang
CHM | Chairman | 59 | 15-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.4848 | -0.84% | 316,995 |
24-04-25 | 0.4889 | -3.26% | 785,274 |
24-04-24 | 0.5054 | +2.77% | 878,438 |
24-04-23 | 0.4918 | +1.78% | 704,400 |
24-04-22 | 0.4832 | -0.68% | 451,590 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.52% | 26.62M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- BIVI Stock